OR6N1: A GPCR Molecule Implicated in Olfactory System (G128372)

OR6N1: A GPCR Molecule Implicated in Olfactory System

OR6N1 (Olfactory Receptor OR1-22) is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR6N1 is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is involved in cell-signaling pathways. OR6N1 is a potent drug target and has been identified as a potential therapeutic target for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

OR6N1 is a member of the superfamily of GPCR, which includes over 700 different proteins that are involved in cell signaling pathways. GPCRs are characterized by the presence of a nucleotide-binding oligomerization (NBD) domain, which is responsible for the interaction with G protein -coupled receptors. OR6N1 contains a NBD domain that is similar to other GPCR NBDs, including the well-known GPCR 伪2未3 receptor.

OR6N1 is expressed in various tissues and organs, including the brain, eye, and nose. It is highly expressed in the olfactory system, where it is involved in the sense of smell. OR6N1 is responsible for the detection of volatile organic compounds (VOCs) , which are odorants that are responsible for the sense of smell. OR6N1 is also involved in the regulation of olfactory receptor function, which is critical for the sense of smell.

OR6N1 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. One of the main reasons for its potential as a drug target is its high expression in the olfactory system, which makes it an attractive target for drugs that can modulate its function. Additionally, OR6N1 is involved in several cellular signaling pathways, which makes it an attractive target for drugs that can modulate its activity.

OR6N1 has been shown to be involved in several cellular signaling pathways, including the TGF-β pathway, the Wnt pathway, and theNotch pathway. The TGF-β pathway is involved in cell growth, differentiation, and survival, and is a well-established target for drugs that can modulate its activity. OR6N1 has been shown to be involved in TGF-β signaling in the olfactory system, which is responsible for the development and maintenance of the olfactory system.

In addition to its involvement in TGF-β signaling, OR6N1 is also involved in the Wnt pathway. The Wnt pathway is involved in cell-cycle progression, angiogenesis, and development, and is a well-established target for drugs that can modulate its activity . OR6N1 has been shown to be involved in Wnt signaling in the olfactory system, which is responsible for the development and maintenance of the olfactory system.

OR6N1 is also involved in the Notch pathway, which is involved in cell-monitoring, cell-adhesion, and neurotransmitter signaling. The Notch pathway is a well-established target for drugs that can modulate its activity, and has been shown to be involved in the regulation of OR6N1 function in the olfactory system.

In conclusion, OR6N1 is a GPCR that is involved in the sense of smell and several cellular signaling pathways, including the TGF-β, Wnt, and Notch pathways. Its high expression in the olfactory system makes it an attractive target for drugs that can modulate its activity, and its involvement in several cellular signaling pathways makes it a potential drug target for various diseases. Further research is needed to fully understand the role of OR6N1 in the olfactory system and its potential as a drug target.

Protein Name: Olfactory Receptor Family 6 Subfamily N Member 1

Functions: Odorant receptor

The "OR6N1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR6N1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4 | ORC5 | ORC6 | Orexin receptor | Organic anion transporters (OATs) | Organic cation transporter | Origin recognition complex